Consulting communities on feedback of genetic findings in international health research: sharing sickle cell disease and carrier information in coastal Kenya

BackgroundInternational health research in malaria-endemic settings may include screening for sickle cell disease, given the relationship between this important genetic condition and resistance to malaria, generating questions about whether and how findings should be disclosed. The literature on disclosing genetic findings in the context of research highlights the role of community consultation in understanding and balancing ethically important issues from participants’ perspectives, including social forms of benefit and harm, and the influence of access to care. To inform research practice locally, and contribute to policy more widely, this study aimed to explore the views of local residents in Kilifi County in coastal Kenya on how researchers should manage study-generated information on sickle cell disease and carrier status.MethodsBetween June 2010 and July 2011, we consulted 62 purposively selected Kilifi residents on how researchers should manage study-generated sickle cell disease findings. Methods drew on a series of deliberative informed small group discussions. Data were analysed thematically, using charts, to describe participants’ perceptions of the importance of disclosing findings, including reasoning, difference and underlying values. Themes were derived from the underlying research questions and from issues emerging from discussions. Data interpretation drew on relevant areas of social science and bioethics literature.ResultsPerceived health and social benefits generated strong support for disclosing findings on sickle cell disease, but the balance of social benefits and harms was less clear for sickle cell trait. Many forms of health and social benefits and harms of information-sharing were identified, with important underlying values related to family interests and the importance of openness. The influence of micro and macro level contextual features and prioritization of values led to marked diversity of opinion.ConclusionsThe approach demonstrates a high ethical importance in many malaria endemic low-to-middle income country settings of disclosing sickle cell disease findings generated during research, alongside provision of effective care and locally-informed counselling. Since these services are central to the benefits of disclosure, health researchers whose studies include screening for sickle cell disease should actively promote the development of health policy and services for this condition in situations of unmet need, including through the prior development of collaborative partnerships with government health managers and providers. Community consultation can importantly enrich ethical debate on research practice where in-depth exploration of informed views and the potential for difference are taken into account.

[1]  J. Scott,et al.  Effectiveness of Haemophilus influenzae type b Conjugate vaccine introduction into routine childhood immunization in Kenya. , 2006, JAMA.

[2]  S. Bull,et al.  Consent and Community Engagement in Diverse Research Contexts: Reviewing and Developing Research and Practice , 2013 .

[3]  G. N. Bazuaye,et al.  Knowledge and attitude of senior secondary school students in Benin City, Nigeria to sickle cell disease , 2009 .

[4]  G. Widdershoven,et al.  Empirical Ethics as Dialogical Practice , 2009, Bioethics.

[5]  Anand P. Patil,et al.  Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates , 2013, The Lancet.

[6]  K. Marsh,et al.  Sickle cell disease in Africa: burden and research priorities , 2007, Annals of tropical medicine and parasitology.

[7]  J. Ives ‘Encounters with Experience’: Empirical Bioethics and the Future , 2008, Health Care Analysis.

[8]  Ezekiel J Emanuel,et al.  What makes clinical research in developing countries ethical? The benchmarks of ethical research. , 2004, The Journal of infectious diseases.

[9]  B. Knoppers,et al.  The emergence of an ethical duty to disclose genetic research results: international perspectives , 2006, European Journal of Human Genetics.

[10]  D. Parkin The Sacred Void by David Parkin , 1991 .

[11]  D J Weatherall,et al.  Inherited haemoglobin disorders: an increasing global health problem. , 2001, Bulletin of the World Health Organization.

[12]  M. Parker Public deliberation and private choice in genetics and reproduction , 2000, Journal of medical ethics.

[13]  D. Jamison,et al.  Disease Control Priorities in Developing Countries , 1993 .

[14]  George Church,et al.  Ethical and Practical Guidelines for Reporting Genetic Research Results to Study Participants: Updated Guidelines from a National Heart, Lung, and Blood Institute Working Group , 2010, Circulation. Cardiovascular genetics.

[15]  H. Richardson,et al.  Medical researchers' ancillary clinical care responsibilities , 2004, BMJ : British Medical Journal.

[16]  K. Horstman,et al.  Genetics, health care, family and kinship in a global perspective: situated processes of co-construction. , 2011, Social science & medicine.

[17]  B. Wilfond,et al.  Disclosing Individual Genetic Results to Research Participants , 2006, The American journal of bioethics : AJOB.

[18]  H. Draper,et al.  Appropriate Methodologies for Empirical Bioethics: It'S All Relative , 2009, Bioethics.

[19]  R. Hayeems,et al.  Questioning the consensus: managing carrier status results generated by newborn screening. , 2009, American journal of public health.

[20]  F. Miller The complex promise of newborn screening. , 2009, Indian journal of medical ethics.

[21]  K. Marsh,et al.  Understanding of informed consent in a low-income setting: three case studies from the Kenyan Coast. , 2004, Social science & medicine.

[22]  P. Ossorio Letting the Gene Out of the Bottle: A Comment on Returning Individual Research Results to Participants , 2006, The American journal of bioethics : AJOB.

[23]  T. Williams,et al.  The Jamaican historical experience of the impact of educational interventions on sickle cell disease child mortality. , 2012, American journal of preventive medicine.

[24]  T. Williams,et al.  Experiences with community engagement and informed consent in a genetic cohort study of severe childhood diseases in Kenya , 2010, BMC medical ethics.

[25]  S. Ballas,et al.  Newborn screening for sickle cell disease. , 1996, Journal of pediatric hematology/oncology.

[26]  R. Fitzpatrick,et al.  Managing misaligned paternity findings in research including sickle cell disease screening in Kenya: ‘Consulting communities’ to inform policy☆ , 2013, Social science & medicine.

[27]  P. Musgrove,et al.  Inherited Disorders of Hemoglobin , 2006 .

[28]  Richard R Sharp,et al.  Community involvement in the ethical review of genetic research: lessons from American Indian and Alaska Native populations. , 2002, Environmental health perspectives.

[29]  P. Lane Sickle cell disease. , 1996, Pediatric clinics of North America.

[30]  M. Parker,et al.  Toward Methodological Innovation in Empirical Ethics Research , 2012, Cambridge Quarterly of Healthcare Ethics.

[31]  C. Grady,et al.  Moral standards for research in developing countries: from "reasonable availability" to "fair benefits". , 2004, The Hastings Center report.

[32]  F. Kirkham,et al.  Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London. , 2007, Haematologica.

[33]  C. Levine One loss may hide another. , 2004, The Hastings Center report.

[34]  Duana Fullwiley Biosocial Suffering: Order and Illness in Urban West Africa , 2006 .

[35]  P. Borry Genetic testing in asymptomatic minors: recommendations of the European Society of Human Genetics , 2009, European Journal of Human Genetics.

[36]  M. Modell The Patient in the Family: An Ethics of Medicine and Families , 1996 .

[37]  M. W. Foster,et al.  Clinical Utility and Full Disclosure of Genetic Results to Research Participants , 2006, The American journal of bioethics : AJOB.

[38]  Judith Green,et al.  Qualitative methods for health research , 2004 .

[39]  R. Snow,et al.  Intra-household relations and treatment decision-making for childhood illness: a Kenyan case study. , 2002, Journal of biosocial science.

[40]  Ogobara K. Doumbo,et al.  Ethical Data Release in Genome-Wide Association Studies in Developing Countries , 2009, PLoS medicine.

[41]  V. Marsh,et al.  ‘All her children are born that way’: gendered experiences of stigma in families affected by sickle cell disorder in rural Kenya , 2011, Ethnicity & health.

[42]  V. Marsh,et al.  Benefits and payments for research participants: Experiences and views from a research centre on the Kenyan coast , 2012, BMC medical ethics.

[43]  A. Bois-pedain,et al.  Freedom and responsibility in reproductive choice , 2006 .

[44]  V. Marsh,et al.  Beginning community engagement at a busy biomedical research programme: Experiences from the KEMRI CGMRC-Wellcome Trust Research Programme, Kilifi, Kenya , 2008, Social science & medicine.

[45]  V. Marsh,et al.  ENGAGING COMMUNITIES TO STRENGTHEN RESEARCH ETHICS IN LOW-INCOME SETTINGS: SELECTION AND PERCEPTIONS OF MEMBERS OF A NETWORK OF REPRESENTATIVES IN COASTAL KENYA , 2013, Developing world bioethics.